Personalized Tobacco Treatment in Primary Care (MOTIVATE)
This study, called MOTIVATE, is looking at two different ways to help people stop smoking: "Precision Treatment" and "Usual Care." Precision Treatment uses your clinical, genetic, and biomarker information to give you personalized recommendations for quitting. Usual Care uses standard practice guidelines. Researchers want to see if Precision Treatment is more effective at helping people quit smoking and if it encourages doctors to prescribe more tobacco treatment medications. You might be able to join if you are 18 or older, smoke at least 5 cigarettes a day, and can speak English. The study will measure if you receive and use tobacco treatment medication, and if you stop smoking, all at 6 months after the intervention. The current status of this study is unclear.
- Study design
- This study is a randomized controlled trial involving 50 clinicians and 800 patients. Participants will be randomly assigned to either the Usual Care or Precision Treatment group.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your smoking cessation will be measured at 6 months after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Li-Shiun Chen, ScD, MD, MPH · PRINCIPAL_INVESTIGATOR · Washington University School of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Patient receipt of tobacco treatment medication for smoking cessation6 months post-intervention
This will be quantified by the proportion of enrolled patients who receive cessation medication.
- Patient use of cessation medication6 months post-intervention
This will be quantified by the proportion of patients taking any cessation medication from time of enrollment through 6 months post-intervention.
- Patient smoking abstinence6 months post-intervention
This will be quantified by the proportion of smokers with bioverified point-prevalent abstinence at 6 months.